Natera Inc
NASDAQ:NTRA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Natera Inc
NASDAQ:NTRA
|
US |
|
P
|
Palma Serasih Tbk PT
IDX:PSGO
|
ID |
|
C
|
Corfacts Inc
OTC:CFCC
|
US |
|
Acanthe Developpement SE
F:ADX
|
FR |
|
Asahimas Flat Glass Tbk PT
IDX:AMFG
|
ID |
|
A
|
Avista Corp
F:AV6
|
US |
|
M
|
Merck KGaA
XMUN:MRK
|
DE |
|
Brixton Metals Corp
XTSX:BBB
|
CA |
|
Obsidian Energy Ltd
TSX:OBE
|
CA |
|
Azuma House Co Ltd
TSE:3293
|
JP |
|
Black Hills Corp
NYSE:BKH
|
US |
|
S
|
Sumitomo Realty & Development Co Ltd
XMUN:RL2
|
JP |
|
P
|
Pt Cipta Perdana Lancar Tbk
IDX:PART
|
ID |
|
Aedifica NV
F:AOO
|
BE |
|
B
|
Bed Bath & Beyond Inc
F:OVER
|
US |
|
T
|
Tutor Perini Corp
F:PE2
|
US |
|
C
|
Compass Inc
NYSE:COMP
|
US |
|
Orient Overseas (International) Ltd
F:ORI
|
HK |
|
Archer Materials Ltd
ASX:AXE
|
AU |
|
C
|
Cleanaway Waste Management Ltd
OTC:TSPCF
|
AU |
|
S
|
Siemens AG
XHAM:SIE
|
DE |
|
NextSource Materials Inc
TSX:NEXT
|
CA |
|
A
|
AES Corp
XMUN:AES
|
US |
|
BASF SE
F:BASA
|
DE |
Intrinsic Value
Is NTRA undervalued or overvalued?
See the intrinsic value estimate for Natera Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Natera Does
Natera is a genetic testing company that analyzes DNA from blood, saliva, or tissue samples to help doctors make medical decisions. Its main products are tests for prenatal screening, hereditary cancer risk, and transplant monitoring, along with tests that help guide care for people with certain cancers. The company sells these tests to hospitals, doctors, cancer centers, and specialty clinics, and it makes money when those tests are ordered and processed.
- Headquarters
- United States of America US
- Employees
- 6 135
- IPO date
- Jul 2, 2015
Natera has a narrow economic moat
Patents protect parts of Natera’s genetic testing methods, while approval to guide a specific bladder cancer treatment gives Signatera a role that rivals cannot simply copy. Its patient-specific test setup also gives doctors a practical reason to keep ongoing monitoring with Natera. These protections apply most clearly to cancer testing rather than equally across all its markets.
Read the full moat analysis
Revenue & Expenses Breakdown
Natera Inc
Earnings Waterfall
Natera Inc
The intrinsic value for Natera Inc (NTRA) under the Base Case is hidden USD.
Compared with the current market price of 389.44 USD, the stock appears hidden.